69 related articles for article (PubMed ID: 9224565)
1. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
[TBL] [Abstract][Full Text] [Related]
2. p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair.
Mak VC; Li X; Rao L; Zhou Y; Tsao SW; Cheung LW
Neoplasia; 2021 Jul; 23(7):718-730. PubMed ID: 34144267
[TBL] [Abstract][Full Text] [Related]
3. Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.
Lee MS; Wan J; Goldman D
Elife; 2020 May; 9():. PubMed ID: 32396062
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors.
Heppner DE; Günther M; Wittlinger F; Laufer SA; Eck MJ
J Med Chem; 2020 Apr; 63(8):4293-4305. PubMed ID: 32243152
[TBL] [Abstract][Full Text] [Related]
5. Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.
You W; Chang CA
J Chem Inf Model; 2018 May; 58(5):968-981. PubMed ID: 29620886
[TBL] [Abstract][Full Text] [Related]
6. Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.
Falk MD; Liu W; Bolaños B; Unsal-Kacmaz K; Klippel A; Grant S; Brooun A; Timofeevski S
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919031
[TBL] [Abstract][Full Text] [Related]
7. Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.
Bagley MC; Davis T; Murziani PG; Widdowson CS; Kipling D
Pharmaceuticals (Basel); 2010 Jun; 3(6):1842-1872. PubMed ID: 27713332
[TBL] [Abstract][Full Text] [Related]
8. Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ.
Kondoh Y; Honda K; Hiranuma S; Hayashi T; Shimizu T; Watanabe N; Osada H
Sci Rep; 2016 Jul; 6():29881. PubMed ID: 27431267
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel Substituted N,N'-Diaryl ureas as Potent p38 Inhibitors.
Zhu D; Li X; Zhong W; Zhao D
Molecules; 2015 Sep; 20(9):16604-19. PubMed ID: 26378516
[TBL] [Abstract][Full Text] [Related]
10. Suppression of problematic compound oligomerization by cosolubilization of nondetergent sulfobetaines.
Mizukoshi Y; Takeuchi K; Arutaki M; Takizawa T; Hanzawa H; Takahashi H; Shimada I
ChemMedChem; 2015 Apr; 10(4):736-41. PubMed ID: 25760302
[TBL] [Abstract][Full Text] [Related]
11. Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases.
Brown KM; Suvorova E; Farrell A; McLain A; Dittmar A; Wiley GB; Marth G; Gaffney PM; Gubbels MJ; White M; Blader IJ
PLoS Pathog; 2014 Jun; 10(6):e1004180. PubMed ID: 24945800
[TBL] [Abstract][Full Text] [Related]
12. The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.
Duffy JP; Harrington EM; Salituro FG; Cochran JE; Green J; Gao H; Bemis GW; Evindar G; Galullo VP; Ford PJ; Germann UA; Wilson KP; Bellon SF; Chen G; Taslimi P; Jones P; Huang C; Pazhanisamy S; Wang YM; Murcko MA; Su MS
ACS Med Chem Lett; 2011 Oct; 2(10):758-63. PubMed ID: 24900264
[TBL] [Abstract][Full Text] [Related]
13. A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.
Li J; Kaoud TS; LeVieux J; Gilbreath B; Moharana S; Dalby KN; Kerwin SM
Chembiochem; 2013 Jan; 14(1):66-71. PubMed ID: 23225637
[TBL] [Abstract][Full Text] [Related]
14. Lamin B1 loss is a senescence-associated biomarker.
Freund A; Laberge RM; Demaria M; Campisi J
Mol Biol Cell; 2012 Jun; 23(11):2066-75. PubMed ID: 22496421
[TBL] [Abstract][Full Text] [Related]
15. Rational approaches to improving selectivity in drug design.
Huggins DJ; Sherman W; Tidor B
J Med Chem; 2012 Feb; 55(4):1424-44. PubMed ID: 22239221
[No Abstract] [Full Text] [Related]
16. Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury.
Zhou F; Onizawa S; Nagai A; Aoshiba K
Respir Res; 2011 Jun; 12(1):78. PubMed ID: 21663649
[TBL] [Abstract][Full Text] [Related]
17. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
Freund A; Patil CK; Campisi J
EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
[TBL] [Abstract][Full Text] [Related]
18. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.
Ibrahim AS; El-Remessy AB; Matragoon S; Zhang W; Patel Y; Khan S; Al-Gayyar MM; El-Shishtawy MM; Liou GI
Diabetes; 2011 Apr; 60(4):1122-33. PubMed ID: 21317295
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy.
Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H
Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389
[TBL] [Abstract][Full Text] [Related]
20. ERK and not p38 pathway is required for IL-12 restoration of T cell IL-2 and IFN-gamma in a rodent model of alcohol intoxication and burn injury.
Li X; Chaudry IH; Choudhry MA
J Immunol; 2009 Sep; 183(6):3955-62. PubMed ID: 19710466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
